Position in NAGE
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$112,036
-$131,450 QoQ
Shares Held
25,405
-33.6% QoQ
Ownership
0.032%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2021
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NAGE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026State of Wyoming holds $10,984,351 across 71 Biotechnology names. NAGE ranks #29 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MDXG |
Mimedx Group, Inc.
|
163,115 | $644,304 | |
| 2 | ADMA |
Adma Biologics, Inc.
|
60,978 | $549,411 | |
| 3 | FTRE |
Fortrea Holdings Inc.
|
54,857 | $516,752 | |
| 4 | PBYI |
Puma Biotechnology, Inc.
|
75,808 | $484,413 | |
| 5 | HALO |
Halozyme Therapeutics, Inc.
|
7,258 | $469,084 | |
| 6 | ARQT |
Arcutis Biotherapeutics, Inc.
|
18,434 | $434,305 | |
| 7 | STOK |
Stoke Therapeutics, Inc.
|
13,262 | $431,810 | |
| 8 | ZYME |
Zymeworks Inc.
|
17,148 | $429,385 |
All Filings in NAGE
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $112,036 | 25,405 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $243,486 | 38,284 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $396,683 | 42,517 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $295,923 | 20,536 | Shares | Sole | 2025-08-19 | |
| 2025-03-31 | $210,553 | 30,515 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $39,140 | 7,371 | Shares | Sole | 2025-02-14 | |
| 2022-03-31 | $11,038 | 4,487 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $32,758 | 8,759 | Shares | Sole | 2022-02-11 | |
| No filing history on record for this holder in this stock. | ||||||